EXPERIENCE OF USING THE DRUG SELEXIPAG IN THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION

被引：0
|
作者：
Karelkina, E. V. [1 ]
Goncharova, N. S. [1 ]
Simakova, M. A. [1 ]
Moiseeva, O. M. [1 ]
机构：
[1] FGBU Natl Med Res Ctr, St Petersburg, Russia
来源：
KARDIOLOGIYA | 2020年 / 60卷 / 04期
关键词：
PROSTACYCLIN-RECEPTOR AGONIST;
D O I：
10.18087/cardio.2020.4.n1026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：36 / 42
页数：6
相关论文
共 50 条
  • [21] Selexipag Dosing Strategies for Pediatric Patients with Pulmonary Arterial Hypertension
    Grossman, Madeline
    Walker, Stephen
    Ramsey, E. Zachary
    PEDIATRIC CARDIOLOGY, 2024, : 902 - 907
  • [22] Clinical pharmacology, efficacy, and safety of selexipag for the treatment of pulmonary arterial hypertension
    Bruderer, Shirin
    Hurst, Noemie
    Remenova, Tatiana
    Dingemanse, Jasper
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 743 - 751
  • [23] SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION - AN UPDATED META-ANALYSIS
    Azevedo, Taina
    Armelin, Larissa
    Pereira, Jussara
    Gauza, Mateus De Miranda
    Fernandes, Amanda
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1903 - 1903
  • [24] Selexipag in the management of pulmonary arterial hypertension: an update
    Coghlan, J. Gerry
    Picken, Christina
    Clapp, Lucie H.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2019, 11 : 55 - 64
  • [25] INDIRECT TREATMENT COMPARISON AND COSTMINIMIZATION ANALYSIS OF RIOCIGUAT VERSUS SELEXIPAG IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
    Ornstova, E.
    Tuzil, J.
    Chadimova, K.
    Mlcoch, T.
    Dolezal, T.
    VALUE IN HEALTH, 2022, 25 (12) : S111 - S111
  • [26] Single Center Experience In Transitioning Pulmonary Arterial Hypertension Patients From Intravenous Epoprostenol To Oral Selexipag
    Safdar, Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] Selexipag real-world experience in patients over 75 yrs with pulmonary arterial hypertension (PAH)
    Gaine, Sean
    Escribano, Pilar
    Biedermann, Patricia
    Muller, Audrey
    Sun, Hong
    Soderberg, Stefan
    Lange, Tobias J.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [28] Early Canadian Experience Using Selexipag as Part of an Oral Triple Therapy Regimen in Pediatric Patients With Severe Pulmonary Arterial Hypertension
    Averin, Konstantin
    Richards, Susan
    Vorhies, Erika
    Bates, Angela
    CIRCULATION, 2019, 140
  • [29] An evaluation of selexipag for the treatment of pulmonary hypertension
    Panagiotidou, Evangelia
    Boutou, Afroditi
    Pitsiou, Georgia
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (01) : 29 - 36
  • [30] BUDGET-IMPACT OF SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Bilir, S. P.
    Beaudet, A.
    Zervoudaki, A.
    Lamprou, C.
    Maniadakis, N.
    VALUE IN HEALTH, 2017, 20 (09) : A641 - A642
12345